Arovella Therapeutics Limited (ALA.AX)

ASX - ASX Delayed price. Currency in AUD

Add to watchlist

0.1070

+0.0020

(+1.90%)

As of 10:00AM AEST. Market open.

Loading interactive chart…

Simply Wall St.
While shareholders of Arovella Therapeutics (ASX:ALA) are in the black over 1 year, those who bought a week ago aren't so fortunate
It certainly might concern Arovella Therapeutics Limited ( ASX:ALA ) shareholders to see the share price down 31% in...
PR Newswire
The SparX Group Enters into a Collaboration with Arovella Therapeutics for the Development of CLDN18.2-CAR-iNKT Cell Therapy
Signifying a monumental step forward in the domain of powered antibody therapies, the SparX Group is thrilled to unveil its strategic alliance with Arovella Therapeutics Ltd (ASX: ALA). This collaboration emphasizes the utilization of SPX-101, an innovative monoclonal antibody (mAb) that targets the Claudin 18.2 (CLDN18.2) tumor specific antigen, as an exciting component in Arovella's CLDN18.2-CAR-iNKT cells as a leading off-the-shelf CAR-iNKT cell therapy.